Literature DB >> 33401440

The Impact of ABO Blood Grouping on COVID-19 Vulnerability and Seriousness: A Retrospective Cross-Sectional Controlled Study among the Arab Community.

Nagla A El-Shitany1,2, Manal El-Hamamsy3,4, Ahlam A Alahmadi5, Basma G Eid1, Thikryat Neamatallah1, Haifa S Almukadi1, Rana A Arab6, Khadija A Faddladdeen5, Khayria A Al-Sulami7, Safia M Bahshwan8, Soad S Ali9, Steve Harakeh10, Shaimaa M Badr-Eldin11,12.   

Abstract

Background and
Objectives: Studies have noted that some ABO blood types are more susceptible to COVID-19 virus infection. This study aimed to further confirm the relationship between different blood groups on the vulnerability, symptoms, cure period, and severity among COVID-19 recovered patients. Subjects and
Methods: This cross-sectional study approached the participants from the Arab community via social media (mainly Facebook and WhatsApp). The data were collected through two Google Form questionnaires, one for COVID-19 recovered patients (COVID-19 group, n = 726), and the other for the healthy people (Control group, n = 707).
Results: The subjects with blood group O were the least likely to be infected with the COVID-19 virus, while those with blood group A were not likely to be the most susceptible. There were significant differences among different ABO blood groups regarding the distribution of oxygen saturation percentage, myalgia, and recovery time after COVID-19 infection (p < 0.01, 0.01, and 0.05, respectively). The blood group A showed the highest percentage of patients who experienced an oxygen saturation range of 90-100%, whereas the blood group O showed the highest percentage of patients who experienced an oxygen saturation range of 70-80%. The blood group A showed the lowest percentage of patients who required artificial respiration, whereas the blood group O showed the highest percentage of patients who required artificial respiration. The blood group B showed the lowest percentage of patients who experienced myalgia and exhibited the lowest percentage of patients who needed 3 weeks or more to recover.
Conclusion: The people of blood group O may be the least likely to be infected with COVID-19, however, they may be the more in need of treatment in hospital and artificial respiration compared to the other blood groups.

Entities:  

Keywords:  COVID-19; artificial respiration; blood group; myalgia; oxygen saturation

Mesh:

Substances:

Year:  2021        PMID: 33401440      PMCID: PMC7795413          DOI: 10.3390/ijerph18010276

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  50 in total

1.  The Novel Coronavirus SARS-CoV-2 Vulnerability Association with ABO/Rh Blood Types.

Authors:  Alireza Abdollahi; Maedeh Mahmoudi-Aliabadi; Vahid Mehrtash; Bita Jafarzadeh; Mohammadreza Salehi
Journal:  Iran J Pathol       Date:  2020-05-23

2.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

3.  Relationship between the ABO Blood Group and the COVID-19 Susceptibility.

Authors:  Jiao Zhao; Yan Yang; Hanping Huang; Dong Li; Dongfeng Gu; Xiangfeng Lu; Zheng Zhang; Lei Liu; Ting Liu; Yukun Liu; Yunjiao He; Bin Sun; Meilan Wei; Guangyu Yang; Xinghuan Wang; Li Zhang; Xiaoyang Zhou; Mingzhao Xing; Peng George Wang
Journal:  Clin Infect Dis       Date:  2020-08-04       Impact factor: 9.079

4.  Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis.

Authors:  Bing-Bing Wu; Dong-Zhou Gu; Jia-Ning Yu; Jie Yang; Wang-Qin Shen
Journal:  Infect Genet Evol       Date:  2020-07-30       Impact factor: 3.342

5.  Blood type and outcomes in patients with COVID-19.

Authors:  Christopher A Latz; Charles DeCarlo; Laura Boitano; C Y Maximilian Png; Rushad Patell; Mark F Conrad; Matthew Eagleton; Anahita Dua
Journal:  Ann Hematol       Date:  2020-07-12       Impact factor: 3.673

6.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

7.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D A M P J Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-10       Impact factor: 3.944

8.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

9.  Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression.

Authors:  Fumiichiro Yamamoto; Miyako Yamamoto; Eduardo Muñiz-Diaz
Journal:  Vox Sang       Date:  2020-09-23       Impact factor: 2.996

View more
  6 in total

Review 1.  The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review.

Authors:  Pourya Shokri; Saeid Golmohammadi; Maryam Noori; Seyed Aria Nejadghaderi; Kristin Carson-Chahhoud; Saeid Safiri
Journal:  Rev Med Virol       Date:  2021-05-14       Impact factor: 11.043

2.  ABO Blood Group and Outcomes in Patients with COVID-19 Admitted in the Intensive Care Unit (ICU): A Retrospective Study in a Tertiary-Level Hospital in Bangladesh.

Authors:  Mohammad Rabiul Halim; Shuvajit Saha; Injamam Ull Haque; Sadia Jesmin; Rahatul Jannat Nishat; A S M D Ashraful Islam; Seema Roy; Miah Md Akiful Haque; Md Motiul Islam; Tarikul Hamid; Kazi Nuruddin Ahmed; Md Azharul Islam Talukder; Arif Ahmed; Emran Hasan; Nurjahan Ananna; Faroque Md Mohsin; Mohammad Delwer Hossain Hawlader
Journal:  J Multidiscip Healthc       Date:  2021-09-02

3.  Early high-titer convalescent plasma therapy in patients with moderate and severe COVID-19.

Authors:  Alieh Fazeli; Shahin Sharifi; Fatemeh Behdad; Shamsi Okati; Gilda Esmaielifar; Nooshin Jelveh; Peyman Eshghi; Saeed Mohammadi
Journal:  Transfus Apher Sci       Date:  2021-11-24       Impact factor: 2.596

4.  Systematic review and meta-analysis of the effect of ABO blood group on the risk of SARS-CoV-2 infection.

Authors:  George Balaouras; Paolo Eusebi; Polychronis Kostoulas
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

5.  Blood-Type-A Is A COVID-19 Infection And Hospitalization Risk In A Turkish Cohort.

Authors:  Meryem Cetin; Sirin Cetin; Ayse Ulgen; Wentian Li
Journal:  Transfus Clin Biol       Date:  2022-10-12       Impact factor: 2.126

6.  An AHP-based regional COVID-19 vulnerability model and its application in China.

Authors:  Zekun Gao; Yutong Jiang; Junyu He; Jiaping Wu; Jian Xu; George Christakos
Journal:  Model Earth Syst Environ       Date:  2021-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.